Protocol to analyze the transmigration efficiency of T. brucei using an in vitro model of the blood-cerebrospinal fluid barrier
Summary: At present, the only approach to investigate the transmigration of Trypanosoma brucei, the causative agent of human African trypanosomiasis, from blood to cerebrospinal fluid is through animal experiments. This protocol details how to analyze the transmigration efficiency using an in vitro...
Main Authors: | Alexander Herrmann, Carolin Susanne Schnedermann, Hiroshi Ishikawa, Christian Schwerk, Horst Schroten, Stefan Mogk |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | STAR Protocols |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666166722005561 |
Similar Items
-
Echovirus-30 Infection Alters Host Proteins in Lipid Rafts at the Cerebrospinal Fluid Barrier In Vitro
by: Marie Wiatr, et al.
Published: (2020-12-01) -
REGULATION OF AMYLOID-ΒETA TRANSPORTERS BY TRANSTHYRETIN - IMPLICATIONS FOR BRAIN PROTECTION AT THE BLOOD-CEREBROSPINAL FLUID BARRIER
by: Tiago Gião, et al.
Published: (2023-10-01) -
In Vitro Models of the Blood–Cerebrospinal Fluid Barrier and Their Applications in the Development and Research of (Neuro)Pharmaceuticals
by: Fatemeh Dabbagh, et al.
Published: (2022-08-01) -
Monitoring fusion kinetics of viral and target cell membranes in living cells using a SARS-CoV-2 spike-protein-mediated membrane fusion assay
by: Hesham Nasser, et al.
Published: (2022-12-01) -
Polar Infection of Echovirus-30 Causes Differential Barrier Affection and Gene Regulation at the Blood–Cerebrospinal Fluid Barrier
by: Marie Wiatr, et al.
Published: (2020-08-01)